Anouk K Trip
Overview
Explore the profile of Anouk K Trip including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hochreuter K, Ren J, Nijkamp J, Korreman S, Lukacova S, Kallehauge J, et al.
Phys Imaging Radiat Oncol
. 2024 Sep;
31:100620.
PMID: 39220114
Background And Purpose: Deep-learning (DL) models for segmentation of the gross tumor volume (GTV) in radiotherapy are generally based on clinical delineations which suffer from inter-observer variability. The aim of...
2.
Trip A, Jensen M, Kallehauge J, Lukacova S
Acta Oncol
. 2019 Jul;
58(10):1532-1535.
PMID: 31303079
No abstract available.
3.
Claassen Y, van Amelsfoort R, Hartgrink H, Dikken J, de Steur W, van Sandick J, et al.
Ann Surg
. 2018 Jul;
270(6):1096-1102.
PMID: 29995679
Objective: We examined the association between surgical hospital volume and both overall survival (OS) and disease-free survival (DFS) using data obtained from the international CRITICS (ChemoRadiotherapy after Induction chemotherapy In...
4.
Cats A, Jansen E, van Grieken N, Sikorska K, Lind P, Nordsmark M, et al.
Lancet Oncol
. 2018 Apr;
19(5):616-628.
PMID: 29650363
Background: Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America. To our knowledge, these treatment strategies have not been investigated...
5.
Claassen Y, de Steur W, Hartgrink H, Dikken J, van Sandick J, van Grieken N, et al.
Ann Surg
. 2017 Aug;
268(6):1008-1013.
PMID: 28817437
Objective: The purpose of this study was to evaluate surgicopathological quality and protocol adherence for lymphadenectomy in the CRITICS trial. Summary Of Background Data: Surgical quality assurance is a key...
6.
Trip A, Stiekema J, Visser O, Dikken J, Cats A, Boot H, et al.
Acta Oncol
. 2015 Mar;
54(10):1754-62.
PMID: 25797568
Background: In recent years, evidence supporting multimodality treatment for oesophageal, oesophagogastric junction (OGJ), and gastric cancer has accumulated. This population-based cohort-study investigates trends and predictors of utilisation of multimodality treatment...
7.
Stiekema J, Trip A, Jansen E, Aarts M, Boot H, Cats A, et al.
Ann Surg Oncol
. 2014 Aug;
22(2):581-8.
PMID: 25164039
Objective: The aim of this study was to investigate the impact of adjuvant chemoradiotherapy (CRT) on survival of non-metastatic gastric cancer patients who had undergone an R1 resection. Methods: We...
8.
Trip A, Poppema B, van Berge Henegouwen M, Siemerink E, Beukema J, Verheij M, et al.
Radiother Oncol
. 2014 May;
112(2):284-8.
PMID: 24856116
Objectives: This study was initiated to investigate the feasibility and efficacy of preoperative radiotherapy with weekly paclitaxel and carboplatin in locally advanced gastric cancer. Methods: In a prospective study, patients...
9.
Stiekema J, Trip A, Jansen E, Boot H, Cats A, Balague Ponz O, et al.
Ann Surg Oncol
. 2013 Dec;
21(4):1107-14.
PMID: 24306660
Background: A microscopically irradical (R1) resection is a well-known adverse prognostic factor after gastric cancer surgery. However, the prognostic significance of an R1 resection in gastric cancer patients who are...